2Velez G, Roy CE, Whiptcup SM, et al. High-dose intravitreal ganciclovir and foscarnet for cyto-megalovirus retinits[J]. Am J Ophthalmol,2001,131(3) :396 - 397
3Frenkel LM, Capparelli EV, Dankner WM, et al. Oral ganciclovir in children: pharmacokinetics, safety, tolerance, and antiviral effects, the pediatric AIDS chinical trial group [J ]. J Infect Dis, 2000, 182 ( 6 ):1016 - 1024
4Mouly S, Aymard G, Diquet B, et al. Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss[J].J Acquir Immune Defic Syndr,2000,24(4) :344 - 351
5Dubrenil-Lemaire ML,Gori A, Vittecoq D, et al. Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for Cytomegalovirus infection:a randomised, placebo-controlled trial in AIDS patients[J ]. Eur J Haematol, 2000,65 (5): 337 - 343
2Johnson RW, Wasner G, Saddier P,et al. Herpes zoster and posther- petic neuralgia [ J ] : optimizing management in the elderly patient. Drugs Aging,2008,25 ( 12 ) :991-1006.
3Gauthier A, Breuer J, Carrington D, et al. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom [ J ]. Epidemiol Infect,2009,137 ( 1 ) : 38-47.
4Stein AN, Britt H, Harrison C, et al. Herpes zoster burden of illness and health care Resource utilisation in the Australian population aged 50 years and older[J]. Vaccine,2009,27(4) :520-529.
5杨啸宇,牟双梦.带状疱疹526例误诊分析[J].中国美容医学,2010,19:16-17.
6Altmeyer P, Hoffmann K, Stucker M. et al. General phenomena of ul- trasound in dermatology [ J ]. Ultrasound in Dermatology Berlin:Spri- ngerVerlag, 1992.55-79.
7Rajalakshmi R,Thappa DM. Acyclovir versus valacyclovir [ J ]. Indi- an J Dermatol Venereol Lepro1,2010,76 (4) :439-444.
